Vytorin [Ezetimibe/simvastatin] as strategy to reduce dislipidemia in adults

Trial Profile

Vytorin [Ezetimibe/simvastatin] as strategy to reduce dislipidemia in adults

Phase of Trial: Phase III

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Ezetimibe/simvastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 23 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top